Press Releases | Medtronic

Month Year

Email alerts

May 15, 2012

Medtronic Announces 2012 Analyst Meeting and Webcast

MINNEAPOLIS--(BUSINESS WIRE)--May. 15, 2012-- Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Friday, June 1, 2012, in New York City from 9:00 a.m. to...
May 15, 2012

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

With Latest Certifications, Company’s Flagship DES Has Broadest Range of Approved Indications in Europe; Study Findings Presented at EuroPCR

PARIS--(BUSINESS WIRE)--May. 15, 2012-- As EuroPCR 2012 gets under way today, Medtronic, Inc. (NYSE: MDT) announced that the Resolute Integrity Coronary Stent System has received European...
May 11, 2012

New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

Study Reinforces Clinical and Economic Validity of Expanded Indication for Medtronic CRT-D Devices

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 11, 2012-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in...
May 10, 2012

Study Shows Longer Arrhythmia Detection Window Reduces Shocks for Medtronic Implantable Defibrillator Patients

Late-Breaking Clinical Trial Validates Medtronic Proprietary Device Algorithms

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 10, 2012-- Medtronic, Inc. (NYSE: MDT) today announced results from the first and only clinical trial to show that Medtronic cardiac devices can safely...
May 10, 2012

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2012

MINNEAPOLIS--(BUSINESS WIRE)--May. 10, 2012-- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2012 on Tuesday, May 22, 2012. A...
May 8, 2012

Medtronic Expands Availability of Valiant(R) Captivia(R) Stent Graft in Major Global Markets

Implantable Medical Device for Endovascular Repair of Thoracic Aortic Aneurysms Also Being Studied for Minimally Invasive Treatment of Blunt Thoracic Aortic Injuries

MINNEAPOLIS--(BUSINESS WIRE)--May. 8, 2012-- Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. (NYSE: MDT) is expanding availability of the Valiant®...
Apr 30, 2012

Eighteen North Suburban High School Graduates Named 2012 Medtronic Scholars

Medtronic Foundation has committed nearly $1.5 million in local scholarships.

MINNEAPOLIS--(BUSINESS WIRE)--Apr. 30, 2012-- The Medtronic Foundation today announced that 18 students have been selected as 2012 Medtronic Scholars. Each will receive a four-year scholarship...
Apr 27, 2012

Trial of Medtronic Symplicity(TM) Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

Six Month Pooled Outcomes From Randomized and Crossover Patients Following Renal Denervation Presented at the 22nd Annual Scientific Meeting of the European Society of Hypertension Confirm Previous Symplicity Clinical Trial Findings

MINNEAPOLIS & LONDON, Apr 27, 2012 (BUSINESS WIRE) --Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical...
Apr 24, 2012

Medtronic Named One of America's Best Corporate Citizens

Medical Technology Leader Ranked in Top 50 on Corporate Responsibility Magazine's 100 Best Corporate Citizens List

MINNEAPOLIS, Apr 24, 2012 (BUSINESS WIRE) --Medtronic, Inc. is one of America's best corporate citizens, according to the rankings recently released by Corporate Responsibility magazine. Medtronic...
Apr 17, 2012

Medtronic Announces Global Drug-Eluting Balloon Study

International Research Program Will Collect and Assess Safety and Efficacy Data on IN.PACT Admiral(TM) Drug-Eluting Balloon in Treatment of Peripheral Artery Disease

MINNEAPOLIS & LONDON, Apr 17, 2012 (BUSINESS WIRE) --In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. (NYSE:...

Show per page